Meike Vogler
12PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Apr 04, 2026
Therapeutic potential of BH3-mimetics and NK cell-mediated immunotherapy in T-ALL.Colin Fortner, Alexandra Niedermayer, Melina Maria Bäuerle
|Oct 06, 2025
The BH3-only protein NOXA is essential for apoptosis induction by BH3-mimetics targeting BCL2 or BCL-XL in DLBCL.Nahide Yildirim, Marius Anders, Victoria M Smith
|Jul 07, 2025
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy.Lisa Marie Reindl, Lida Jalili, Tobias Bexte
|Mar 21, 2025
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy.Meike Vogler, Yannick Braun, Victoria M Smith
|Sep 30, 2024
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells.Tobias Bexte, Nawid Albinger, Ahmad Al Ajami
|Aug 27, 2024
Inhibition of bromodomain and extra-terminal proteins targets constitutively active NFκB and STAT signaling in lymphoma and influences the expression of the antiapoptotic proteins BCL2A1 and c-MYC.Nadja M Pieper, Julia Schnell, Daniela Bruecher
Pageof 2
Frequent Collaborators
4 joint publications
Lisa Marie Reindl
4 joint publications
Vinzenz Särchen
3 joint publications
Evelyn Ullrich
2 joint publications
Nadja M Pieper
2 joint publications
Tobias Bexte
1 joint publications
Steffen Gretser
1 joint publications
Carsten Kummerow
1 joint publications
Thomas Bukur
1 joint publications
Martin Suchan
1 joint publications
Dominik C Fuhrmann
